Try our Advanced Search for more refined results
March 17, 2022
Bristol-Myers Squibb Co. et al v. AstraZeneca Pharmaceuticals LP et al
Case Number:
1:22-cv-00346
Court:
Nature of Suit:
Judge:
Firms
Companies
- AstraZeneca PLC
- Bristol-Myers Squibb Co.
- Dana-Farber Cancer Institute Inc.
- Ono Pharmaceutical Co. Ltd
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 01, 2023
AstraZeneca Sets Aside $510M For Bristol-Myers Patent Deal
AstraZeneca has set aside $510 million to resolve Bristol-Myers Squibb Co.'s litigation that it infringed cancer treatment patents to create rival immunotherapy drugs, according to a recent securities filing.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login